Open Search
Close Search
Full Committee Hearing

Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy

Date: 
Time: 
Location:  215 Dirksen Senate Office Building

Meeting Agenda

We encourage the public to utilize the Committee’s livestream of the hearing, available on the website at https://www.finance.senate.gov/.  

Member Statements

  1. Ron Wyden

    D - OR

  2. Mike Crapo

    R - ID

Witnesses

  1. Brad W. Setser

    Council on Foreign Relations
    Washington, DC
    Download Testimony

  2. Daniel Bunn

    President and CEO
    Tax Foundation
    Washington, DC
    Download Testimony

  3. Diane M. Ring

    Boston College Law School
    Boston, MA
    Download Testimony

  4. William Morris

    PwC
    Washington, DC
    Download Testimony

Related Files

  1. Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy

    Download File

  2. Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy

    Download File
Print 
Email 
Share 
Share 

How do I submit a statement for the record?

Any individual or organization wanting to present their views for inclusion in the hearing record should submit in a Word document, a single-spaced statement, not exceeding 10 pages in length. No other file type will be accepted for inclusion. Title and date of the hearing, and the full name and address of the individual or organization must appear on the first page of the statement. Statements must be received no later than two weeks following the conclusion of the hearing. Non-compliant submissions will not be accepted. Submissions are not reviewed by policy staff.

Statements can be emailed to:

Statementsfortherecord@finance.senate.gov

Statements can be mailed (not faxed) to:

Senate Committee on Finance
Attn. Editorial and Document Section
Rm. SD-219
Dirksen Senate Office Bldg.
Washington, DC 20510-6200